Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants [Phase 2]

View source ↗

Summary

Phase 2 trial comparing a DTaP-IPV-Hep B-PRP~T combined vaccine with PENTAXIM and ENGERIX B in Argentinean infants has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• DTaP-IPV-Hep B-PRP~T Combined Vaccine
• Engerix-B (hepatitis B vaccine)
• Pentaxim

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 2 | Status: COMPLETED | Results posted: 2013-11-21